摘要
心力衰竭是一种复杂的临床综合征,肾功能不全是心功能不全的常见合并症,心力衰竭患者一旦合并肾功能不全,不仅增加了心力衰竭患者治疗的复杂性,而且提示患者预后不良。如何对这类高风险患者进行早期识别并给予积极干预是目前亟待解决的临床难题,目前一些新型生物标志物的出现,可以有效地为心力衰竭合并肾功能不全提供早期诊断、评估疾病进展及预后评价。
Heart failure is a complex clinical syndrome .Renal impairment is a relative frequent complication in heart failure patients . Renal dysfunction influences the prognosis of patients with heart failure and increases treatment difficulties .It is necessary to provide early di-agnosis and treatment for such patients .Novel biomarkers can provide useful information for early diagnosis ,assessing the progression of dis-ease and estimating prognosis .
出处
《心血管病学进展》
CAS
2017年第2期173-176,共4页
Advances in Cardiovascular Diseases
基金
秦皇岛市科技支撑计划项目(项目编号201502A076)
